柳叶刀糖尿病内分泌 2025; 13: 119-33 更正

IF 44 1区医学 Q1 ENDOCRINOLOGY & METABOLISM

The Lancet Diabetes & Endocrinology Pub Date : 2025-02-03 DOI:10.1016/s2213-8587(25)00021-x

{"title":"柳叶刀糖尿病内分泌 2025; 13: 119-33 更正","authors":"","doi":"10.1016/s2213-8587(25)00021-x","DOIUrl":null,"url":null,"abstract":"Yang J, Burrello J, Goi J, et al. Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort. Lancet Diabetes Endocrinol 2025; 13: 119–33—In this Article, the spelling of author Ying Song's name was incorrect. In this Article, Jun Yang and Renata Libianto have been added to the affiliation, Department of Endocrinology, Monash Health, Clayton, VIC, Australia. In the panel, the third bullet point under the Clinical outcomes subheading has been changed to a footnote, now cited in the second bullet point under the same subheading. The last sentence of the seventh paragraph of the results section has been corrected to read, “Of the participants with a complete clinical response, 160 (70%) were female, whereas of those with an absent clinical response, 88 (39%) were female.” Appendix 14 of this Article has been corrected. These changes have been made to the online version as of Feb 3, 2025.","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"39 1","pages":""},"PeriodicalIF":44.0000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to Lancet Diabetes Endocrinol 2025; 13: 119–33\",\"authors\":\"\",\"doi\":\"10.1016/s2213-8587(25)00021-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Yang J, Burrello J, Goi J, et al. Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort. Lancet Diabetes Endocrinol 2025; 13: 119–33—In this Article, the spelling of author Ying Song's name was incorrect. In this Article, Jun Yang and Renata Libianto have been added to the affiliation, Department of Endocrinology, Monash Health, Clayton, VIC, Australia. In the panel, the third bullet point under the Clinical outcomes subheading has been changed to a footnote, now cited in the second bullet point under the same subheading. The last sentence of the seventh paragraph of the results section has been corrected to read, “Of the participants with a complete clinical response, 160 (70%) were female, whereas of those with an absent clinical response, 88 (39%) were female.” Appendix 14 of this Article has been corrected. These changes have been made to the online version as of Feb 3, 2025.\",\"PeriodicalId\":48790,\"journal\":{\"name\":\"The Lancet Diabetes & Endocrinology\",\"volume\":\"39 1\",\"pages\":\"\"},\"PeriodicalIF\":44.0000,\"publicationDate\":\"2025-02-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet Diabetes & Endocrinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/s2213-8587(25)00021-x\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Diabetes & Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s2213-8587(25)00021-x","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

杨杰，Burrello J, Goi J，等。原发性醛固酮增多症药物治疗后的结果：国际共识和对国际队列治疗反应的分析柳叶刀糖尿病内分泌2025；13:119 - 33在这篇文章中，作者宋颖的名字拼写错误。在这篇文章中，杨君和Renata Libianto加入了隶属关系，内分泌科，莫纳什健康，克莱顿，维多利亚州，澳大利亚。在小组中，临床结果副标题下的第三个要点已更改为脚注，现在在同一副标题下的第二个要点中引用。结果部分第七段的最后一句话已被更正为：“在有完全临床反应的参与者中，160名（70%）是女性，而在没有临床反应的参与者中，88名（39%）是女性。”本文附录14已更正。这些更改已于2025年2月3日对在线版本进行了更改。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to Lancet Diabetes Endocrinol 2025; 13: 119–33

Yang J, Burrello J, Goi J, et al. Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort. Lancet Diabetes Endocrinol 2025; 13: 119–33—In this Article, the spelling of author Ying Song's name was incorrect. In this Article, Jun Yang and Renata Libianto have been added to the affiliation, Department of Endocrinology, Monash Health, Clayton, VIC, Australia. In the panel, the third bullet point under the Clinical outcomes subheading has been changed to a footnote, now cited in the second bullet point under the same subheading. The last sentence of the seventh paragraph of the results section has been corrected to read, “Of the participants with a complete clinical response, 160 (70%) were female, whereas of those with an absent clinical response, 88 (39%) were female.” Appendix 14 of this Article has been corrected. These changes have been made to the online version as of Feb 3, 2025.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Lancet Diabetes & Endocrinology ENDOCRINOLOGY & METABOLISM-

CiteScore

61.50

自引率

1.60%

发文量

371

期刊介绍： The Lancet Diabetes & Endocrinology, an independent journal with a global perspective and strong clinical focus, features original clinical research, expert reviews, news, and opinion pieces in each monthly issue. Covering topics like diabetes, obesity, nutrition, and more, the journal provides insights into clinical advances and practice-changing research worldwide. It welcomes original research advocating change or shedding light on clinical practice, as well as informative reviews on related topics, especially those with global health importance and relevance to low-income and middle-income countries. The journal publishes various content types, including Articles, Reviews, Comments, Correspondence, Health Policy, and Personal Views, along with Series and Commissions aiming to drive positive change in clinical practice and health policy in diabetes and endocrinology.